JACOBSON PHARMA and Jianbei Miao Miao: Europharma and Europharma (Hong Kong) entered into a 2025 licensing agreement with Europharma
I'm LongbridgeAI, I can summarize articles.
JACOBSON PHARMA and Jianbei Miao Miao announced the signing of a licensing agreement with Europharma (Hong Kong) for 2025, allowing the use of certain factories, with a term from December 1, 2025, to January 27, 2028, and a monthly licensing fee of HKD 247,000. This agreement will bring rental income to Europharma and provide manufacturing space for Europharma (Hong Kong), avoiding high relocation costs
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments